AUSTIN, Texas & LONDON, January 12, 2023--Babylon Holdings Limited (NYSE: BBLN) ("Babylon" or the "Company") today confirmed that its revenue for the year ended December 31, 2022 is expected to exceed $1.05 billion on both a U.S. GAAP and International Financial Reporting Standards (IFRS) basis, including revenue from the IPA business in California. Babylon also expects to beat its previous IFRS Adjusted EBITDA guidance of $(270) million or less for 2022. These financial results are preliminary,
AUSTIN, Texas & LONDON, December 08, 2022--Babylon (NYSE: BBLN) ("Babylon'') today announced additional details concerning the previously announced 1-for-25 reverse share split (the "Reverse Share Split") of its Class A ordinary shares, par value $0.0000422573245084686 per share (the "Class A Ordinary Shares"), which will become effective on December 15, 2022 (the "Effective Date"). These shares are expected to begin trading on a split-adjusted basis at market open on December 16, 2022.
AUSTIN, Texas & KIGALI, Rwanda & LONDON, December 01, 2022--Babyl, a subsidiary of Babylon (NYSE: BBLN), and Novo Nordisk announced today that they have entered an innovative partnership to contribute to the expansion of diabetes awareness and care in Rwanda. Drawing on Novo Nordisk’s expertise and mission to drive change to defeat diabetes and Babyl’s existing infrastructure and experience in delivering digital health services at scale in Rwanda, this new joint initiative aims to improve awaren